GURVINDER SODHI: Open Payments
NPI 1477517076 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,188 in 64 payments from 13 companies in 2025. Trend: 2023 $1,649 · 2024 $1,421 · 2025 $1,188
Food & beverage: $1,188
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $226 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $208 |
| Lundbeck LLC | 9 | $177 |
| Merck Sharp & Dohme LLC | 7 | $152 |
| Alkermes, Inc. | 4 | $102 |
| Neurocrine BioSciences, Inc. | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Shionogi Inc | 3 | $57 |
| ABBVIE INC. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
Products named: AUSTEDO XR, CAPLYTA, REXULTI, ZERBAXA, INGREZZA, COBENFY, ARISTADA, Fetroja.
Industry payments across AZ — which companies pay providers there.
